Close Menu
    Facebook X (Twitter) Instagram
    IntelliNews
    Facebook X (Twitter) Instagram
    IntelliNews
    Home»UNITED KINGDOM»The Independent»Immunotherapy drug delays cancer recurring or worsening in global trial
    The Independent

    Immunotherapy drug delays cancer recurring or worsening in global trial

    IntelliNewsBy IntelliNewsmai 31, 2025Aucun commentaire1 Min Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care



    Source link : https://www.independent.co.uk/life-style/health-and-families/immunotherapy-drug-for-cancer-keytruda-trial-b2760713.html

    Author : Storm Newton

    Publish date : 2025-05-30 23:01:00

    Copyright for syndicated content belongs to the linked Source.

    The Independent
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    IntelliNews

      Related Posts

      South Africa v New Zealand LIVE: Latest updates as Springboks and All Blacks collide in first Test

      août 22, 2026

      Lanterns review – DC Comics’ True Detective riff aims higher than the usual superhero guff

      août 14, 2026

      Israeli officials shocked by the speed of Iran’s military recovery after war, report says

      août 14, 2026
      mai 2025
      LMMJVSD
       1234
      567891011
      12131415161718
      19202122232425
      262728293031 
      « Avr   Juin »
      Catégories
      Archives
      Facebook X (Twitter) Instagram Pinterest
      © 2026

      Type above and press Enter to search. Press Esc to cancel.